This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Duan, L. Articles by Yamamoto, K. Search for Related Content PubMed PubMed Citation Articles by Duan, L. Articles by Yamamoto, K.

Impairment of Both Apoptotic and Cytoprotective Signalings in Glioma Cells Resistant to the Combined Use of Cisplatin and Tumor Necrosis Factor

¹Department of Neurosurgery, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan;² Department of Cell Biology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan; and³ Cytometry Group, Beckman Coulter, Tokyo, Japan

Purpose: Tumor necrosis factor (TNF)- elicits two opposing effects, the induction of apoptosis and the transcription of antiapoptotic genes. We have recently shown that cisplatin sensitizes glioma cells to TNF-induced apoptosis, but only in some cell lines. To understand the mechanism involved in the different susceptibilities, we examined both the activation of caspases and cytoprotective signaling by TNF-.

Experimental Design: Caspase activation was examined by estimating the cleavage of substrate peptides and by immunoblot to identify the cleavage of procaspases. Peptide inhibitors of caspases were used to reverse the cytotoxicity. The binding of TNF- to the receptor was analyzed by flow cytometry. Nuclear factor (NF)-B activation was assayed by the binding of NF-B to oligonucleotides containing the consensus binding site. Interleukin (IL)-1ß, IL-6, IL-8, and manganous superoxide dismutase (MnSOD) were measured by enzyme-linked immunoassays.

Results: T98G and U87MG underwent apoptosis on treatment with cisplatin and TNF-, but U373MG and A172 were resistant. Caspases 2, 3, and 6–10, but not caspases 1, 4, and 5, were activated in sensitive cells, and none were activated in resistant cells. The binding of TNF- to the receptor was the same in all four of the cell lines. In the sensitive cells, NF-B activation and the production of IL-1ß, IL-6, IL-8, and MnSOD were significantly elevated by TNF-. However, in the resistant cells, the production of IL-1ß and IL-6 were specifically impaired in response to TNF-.

Conclusions: Our results indicate that both apoptotic and cytoprotective pathways are impaired in glioma cells that are resistant to treatment with cisplatin and TNF-.

This article has been cited by other articles:

				A. Ryo, A. Hirai, M. Nishi, Y.-C. Liou, K. Perrem, S.-C. Lin, H. Hirano, S. W. Lee, and I. Aoki A Suppressive Role of the Prolyl Isomerase Pin1 in Cellular Apoptosis Mediated by the Death-associated Protein Daxx J. Biol. Chem., December 14, 2007; 282(50): 36671 - 36681. [Abstract] [Full Text] [PDF]

				B. Yamini, X. Yu, G. Y. Gillespie, D. W. Kufe, and R. R. Weichselbaum Transcriptional Targeting of Adenovirally Delivered Tumor Necrosis Factor {alpha} by Temozolomide in Experimental Glioblastoma Cancer Res., September 15, 2004; 64(18): 6381 - 6384. [Abstract] [Full Text] [PDF]